Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$2.54
-1.17%
Mkt Cap $394.70M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (22 analysts)
$5.00
Range $4.00 – $6.00
Implied Upside
+97.2%
Consensus $5.00 vs current $2.54
NASDAQ·Healthcare·Biotechnology
$2.54
-1.17%
Mkt Cap $394.70M
Buy
2
Hold
0
Sell
0
Price Target (22 analysts)
$5.00
Range $4.00 – $6.00
+97.2%
Consensus $5.00 vs current $2.54